In addition, several cancer types (e.g., non-small cell lung cancer, cervical squamous cell carcinoma, ESCA, LIHC, SARC, BLCA, and BRCA) had PCSK9 mutations (amplifications or deep deletions). Here, PCSK9 is linked to non-small cell lung carcinoma.